# EDGAR Filing Document

**Accession Number:** 0002079272
**File Stem:** 0001213900-26-054931
**Filing Date:** 2026-5
**Character Count:** 2578
**Document Hash:** 0e8380cb44903015003f6fd16a3caca0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-054931.hdr.sgml**: 20260616

**ACCESSION NUMBER**: 0001213900-26-054931

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260512

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lakewood-Amedex Biotherapeutics Inc.
- **CENTRAL INDEX KEY:** 0002079272
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 205274304
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 8031 COOPER CREEK BLVD.
- **STREET 2:** SUITE 103
- **CITY:** UNIVERSITY PARK
- **STATE:** FL
- **ZIP:** 34201
- **BUSINESS PHONE:** 9412252515

**MAIL ADDRESS:**
- **STREET 1:** 8031 COOPER CREEK BLVD.
- **STREET 2:** SUITE 103
- **CITY:** UNIVERSITY PARK
- **STATE:** FL
- **ZIP:** 34201

**Lakewood-Amedex Biotherapeutics Inc.**

**8031 Cooper Creek Blvd, Unit 103**

**University Park, FL 34201**

**(941) 225-2515**

May 12, 2026

Ms. Doris Stacey Gama

U.S. Securities & Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Lakewood-Amedex Biotherapeutics Inc.** |
|  | **Registration Statement on Form S-1** |
|  | **Filed May 1, 2026**<br> **File No. 333-295497** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Acceleration Request:**<br> **Requested Date: May 13, 2026**<br> **Requested Time: 4:00 P.M. Eastern Time** <br>

Dear Ms. Gama:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Lakewood-Amedex Biotherapeutics Inc. (the "<u>Company</u>") hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-295497) (the "<u>Registration Statement</u>") be declared effective on the "Requested Date" and at the "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Lucosky Brookman LLP, by calling Scott Linsky at (732) 395-4408.

Thank you for your assistance in reviewing this filing. If you have any questions or comments regarding the foregoing, please contact Kelvin Cooper via email at kcooper@lakewoodamedex.com.

Very truly yours,

---

| |
|:---|
| */s/ Kelvin Cooper* |
| Kelvin Cooper |
| Chief Executive Officer |

---

Cc: Scott E. Linsky, Esq.